Science & Enterprise subscription

Follow us on Twitter

  • Make me wanna shout ... #BillsMafia https://t.co/iF1vhKHXtu
    about 1 hour ago
  • First of two podcasts with experiences of news photographers in the insurrection. Thanks @cherissmay for sharing yo… https://t.co/aCjPD6ct84
    about 17 hours ago
  • Half or more of American adults express negative opinions about the way Covid-19 vaccines are distributed, accordin… https://t.co/9l2SUpW85u
    about 23 hours ago
  • New post on Science and Enterprise: Infographic – US Public Down on Vaccine Rollout https://t.co/vegz3ihvIO #Science #Business
    about 23 hours ago
  • We've written several times about Lander and his work, including companies he founded. ... Biden to Elevate Science… https://t.co/rWVGTa1gPL
    about 1 day ago

Please share Science & Enterprise

Registry Tracking Long-Term Covid-19 Impacts

Data pointing finger

A study now underway is tracking long-term effects of Covid-19 infections using real-world data from electronic sources provided by patients. . . . → Read More: Registry Tracking Long-Term Covid-19 Impacts

US Govt to Buy 1.25M Regeneron Covid-19 Therapies

SARS-Cov-2 virus

The U.S. Department of Health and Human Services is buying up to 1.25 million more doses of Regeneron’s Covid-19 antibody therapy, for $2.63 billion. . . . → Read More: US Govt to Buy 1.25M Regeneron Covid-19 Therapies

Drug Price Disruptor Biotech Raises $500M in New Funds

Pills and dollar bill

A start-up biotechnology company that aims to bring drugs to market at lower cost is raising $500 million in its second venture funding round. . . . → Read More: Drug Price Disruptor Biotech Raises $500M in New Funds

CureVac, Bayer Partner on Covid-19 Vaccine Supply

Syringe in hand

Vaccine developer CureVac and global drug maker Bayer are partnering on further development, authorization, and supply of CureVac’s Covid-19 vaccine. . . . → Read More: CureVac, Bayer Partner on Covid-19 Vaccine Supply

Stem Cells Help Severe Covid-19 Cases Recover

lung illustration

Results of a clinical trial show stem cells from umbilical cord linings help patients with severe respiratory disease recover and survive from Covid-19 infections. . . . → Read More: Stem Cells Help Severe Covid-19 Cases Recover

FDA Issues Precision Genomic Drug Guidance

DNA analysis graphic

The U.S. Food and Drug Administration issued draft administrative and procedural guidelines for genetic disorders treated with precise gene therapies. . . . → Read More: FDA Issues Precision Genomic Drug Guidance

Trial OKed for Rare Disease Gene Therapy

Nerve cells illustration

A start-up biotech company says it received clearance from the Food and Drug Administration to begin a clinical trial of its gene therapy for Krabbe disease. . . . → Read More: Trial OKed for Rare Disease Gene Therapy

Large Covid-19 Vaccine Trial Underway in U.S.

Vaccine vials

A biotechnology vaccine developer began enrolling participants in a large-scale clinical trial testing a vaccine to prevent Covid-19 infections. . . . → Read More: Large Covid-19 Vaccine Trial Underway in U.S.

VR Assessed for Job Re-Entry After Brain Injury

Man in virtual reality headset

The Kessler Foundation is studying virtual reality as a tool to help people with traumatic brain injuries prepare to re-enter the work force. . . . → Read More: VR Assessed for Job Re-Entry After Brain Injury

Device-Aided Covid-19 Vaccine Invokes Immune Response

SARS-CoV-2 and cell

Results from an early clinical trial show a Covid-19 vaccine using an electronic device to boost uptake in cells is safe and generates an immune-system response. . . . → Read More: Device-Aided Covid-19 Vaccine Invokes Immune Response